Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements

Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements

Abstract Background When use of a single antiseizure medication (ASM) fails to induce seizure remission, add-on therapy is justified. Perampanel (PER) is approved in Europe as adjunctive therapy for focal, focal to bilateral tonic-clonic seizures and generalized tonic-clonic seizures. Aim of the stu...

Full description

Bibliographic Details
Main Authors: Paolo Bonanni, Antonio Gambardella, Paolo Tinuper, Benedetto Acone, Emilio Perucca, Giangennaro Coppola
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Neurology
Subjects:
Perampanel
Epilepsy
Delphi procedure
Antiepileptic drugs
Adjunctive therapy
Online Access:https://doi.org/10.1186/s12883-021-02450-y

Internet

https://doi.org/10.1186/s12883-021-02450-y

Similar Items